Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Forestry & Wood
- Glassware
- Packaging
- Metal
- Plastics & Resins
- Pulp & Paper
- Waste and Recycling
- Environmental
- Health and Safety
- Air and Climate
- University / Academia / Research
- Government
- Manufacturing, Other
- Publishing / Media / Marketing
- Food and Beverage
- Construction & Construction Materials
Cancer Drug Suppliers & Manufacturers
53 companies found
based inHayward, CALIFORNIA (USA)
Biolog, Inc. is a privately held company that began operations in Northern California in 1984. The company’s product lines have been built upon patented technology that greatly simplifies testing of cells. Biolog’s first products were introduced in ...
based inCherry Hill, NEW JERSEY (USA)
We are a team of experts focused on developing solutions in the biotechnology industry. Founded in 2014, SunP Biotech, LLC is a high-tech research and manufacturing company specialized in 3D Bioprinting. Based on our proprietary technologies, SunP ...
based inMalmö, SWEDEN
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Oncoral is a novel oral irinotecan tablet in ...
Oncoral is a novel daily irinotecan chemotherapy in development. Irinotecan chemotherapy has an established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily irinotecan tablet with the potential to offer better ...
based inYongin, SOUTH KOREA
Bilix is established based on the world’s first PEGylated bilirubin platform technology to produce numerous “First in Class” in anti-inflammatory and “Best in Class” in cancer therapy drugs in addition to achieving other business platform such as ...
based inLund, SWEDEN
SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly ...
based inNew York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...
based inChangsha City, CHINA
Hunan Huateng Pharmaceutical Co., Ltd (hereinafter referred to as Huateng Pharma), was founded in 2013 to manufacture and supply researchers with PEG derivatives and products used across the pharmaceutical value chain including intermediates, ...
(S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate. Huateng Pharmaceutical, a global supplier of Pharmaceutical intermediates, offers Carfilzomib intermediate Boc-HPh-Leu-Phe-Ome (CAS No.: ...
based inDurham, NORTH CAROLINA (USA)
Cancer is the second leading cause of death in the U.S. and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the most effective ...
based inPasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
Pre-clinical studies showed that LB-100 alone inhibits a spectrum of human cancers but when combined with standard cytotoxic drugs and/or radiation, LB-100 potentiates their effectiveness against hematologic and ...
based inOxford, UNITED KINGDOM
Physiomics are a leading oncology consultancy using proprietary state of the art Virtual TumourTM technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs to help ...
based inDoylestown, PENNSYLVANIA (USA)
ImCare Biotech is a biotechnology company founded in 2011 by Dr. Xuanyong Lu, formerly a professor at Drexel University’s Institute for Biotechnology and Virology. The company’s primary products in development are innovative diagnostic biomarkers as ...
Overexpression of a novel apoptosis inhibitor, serine protease inhibitor Kazal (SPIK), has been demonstrated in HCC and other cancer patients. In addition, high levels of SPIK are closely associated with early recurrence in cancer patients following ...
based inMorrisville, NORTH CAROLINA (USA)
NantHealth empowers the creation of integrated healthcare delivery networks. In developing technology that supports systems and data, we enable efficiency, personalized treatment, and collaboration across health care. NantHealth is recognized by ...
Payers, seeking a clearer view into treatment validity, turn to Eviti Connect. Focused on high-quality, high-value care, the platform offers insight payers need to make reimbursement decisions. For payers, Eviti Connect streamlines the ...
based inDoylestown, PENNSYLVANIA (USA)
Diverse Biotech, Inc is an innovative drug-discovery & biopharmaceutical research company committed to discovering and developing novel therapies from its proprietary conjugate drug synthesis Platform. The company originated from oncologists adding ...
based inAmesbury, MASSACHUSETTS (USA)
Gloveboxes Group brings together the expertise of Inert, Erea, and Jacomex, providing a comprehensive range of containment solutions essential for controlled atmospheres and operator safety. The group offers custom and standard gloveboxes, gas ...
Gloveboxes Group specializes in the design and manufacturing of custom isolators tailored for the pharmaceutical industry. These isolators cater to a range of applications, from sterile processes such as weighing, formulation, and sterility testing, ...
based inNew York, NEW YORK (USA)
Creative Peptides is specialized in the process development and the manufacturing of bioactive peptides. We are dedicated to offering custom peptide synthesis, process development, GMP manufacturing as well as catalog products for customers in ...
Synthetic peptides may be useful in structure-function studies of polypeptides, as peptide hormones and hormone analogues, in the preparation of cross-reacting antibodies, and in the design of novel anti-microbial and anti-cancer ...
based inCarlsbad, CALIFORNIA (USA)
Qualigen is a biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack diagnostic platform. The FastPack line of FDA-cleared and ...
QN-247, formerly referred to as ALAN (Aptamer Linked Anti Nucleolin), is an aptamer-based investigational drug candidate currently under development and evaluation with the potential to treat a variety of different ...
based inWaterside, UNITED KINGDOM
Lightpoint Medical is a technology leader in targeted cancer surgery. We are developing miniaturized imaging and sensing tools for more precise intra-operative cancer detection. Our mission is to improve the lives of people with cancer by ...
based inEpalinges, SWITZERLAND
AC BioScience Ltd., a clinical-stage biotech company and a developer of immune modulating and angiogenic cancer therapies. AC BioScience LTD. is a Swiss biotech company, pioneering the development of novel therapies in immuno-oncology and tumor ...
Our product is a new-generation CAP6 that shows great promise as a highly effective treatment for lung cancer (NSCLC). Lung cancer is one of the most widely prevalent cancers, and one of the most difficult to treat. Eighty-one percent of patients ...
based inUtrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
based inSan Diego, CALIFORNIA (USA)
At Kura Oncology, we are committed to realizing the promise of precision medicines for the treatment of cancer. The genomics revolution is transforming how we treat cancer. We now understand that a patient’s response to treatment depends in part on ...